Phenothiazines and thioxanthenes inhibit multidrug efflux pump activity in Staphylococcus aureus.
about
Thioridazine induces major changes in global gene expression and cell wall composition in methicillin-resistant Staphylococcus aureus USA300Sensitization of Staphylococcus aureus to methicillin and other antibiotics in vitro and in vivo in the presence of HAMLETEfflux-mediated drug resistance in bacteria: an updateThioridazine: resurrection as an antimicrobial agent?Integrating high-content imaging and chemical genetics to probe host cellular pathways critical for Yersinia pestis infectionEvaluation of multidrug efflux pump inhibitors by a new method using microfluidic channelsActivity of trifluoperazine against replicating, non-replicating and drug resistant M. tuberculosisRole of efflux pumps and intracellular thiols in natural antimony resistant isolates of Leishmania donovaniCurrent Advances in Developing Inhibitors of Bacterial Multidrug Efflux PumpsCharacterization of the type 2 NADH:menaquinone oxidoreductases from Staphylococcus aureus and the bactericidal action of phenothiazinesPhenothiazinium antimicrobial photosensitizers are substrates of bacterial multidrug resistance pumps.In vitro characterization of the antibacterial spectrum of novel bacterial type II topoisomerase inhibitors of the aminobenzimidazole class.Clinically relevant chromosomally encoded multidrug resistance efflux pumps in bacteriaStructure and function of efflux pumps that confer resistance to drugsThe challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria.Synergistic interaction between phenothiazines and antimicrobial agents against Burkholderia pseudomallei.A microfluidic device for simple and rapid evaluation of multidrug efflux pump inhibitorsEffect of thioridazine on experimental cutaneous staphylococcal infectionsMRSA--what is it, and how do we deal with the problem?Mutagenesis and modeling to predict structural and functional characteristics of the Staphylococcus aureus MepA multidrug efflux pump.Bacterial efflux pump inhibitors from natural sources.Enhanced killing of intracellular multidrug-resistant Mycobacterium tuberculosis by compounds that affect the activity of efflux pumps.Phenothiazines as anti-tubercular agents: mechanistic insights and clinical implications.Yeast ABC proteins involved in multidrug resistance.Pseudomonas aeruginosa: arsenal of resistance mechanisms, decades of changing resistance profiles, and future antimicrobial therapies.Multidrug efflux pumps in Staphylococcus aureus and their clinical implications.Synthesis and In Vitro Antiproliferative Activity of Novel Phenyl Ring-Substituted 5-Alkyl-12(H)-quino[3,4-b][1,4]benzothiazine Derivatives.Efflux-mediated response of Staphylococcus aureus exposed to ethidium bromide.Capsaicin, a novel inhibitor of the NorA efflux pump, reduces the intracellular invasion of Staphylococcus aureus.Searching for Novel Inhibitors of the S. aureus NorA Efflux Pump: Synthesis and Biological Evaluation of the 3-Phenyl-1,4-benzothiazine Analogues.Inhibition of antibiotic efflux in bacteria by the novel multidrug resistance inhibitors biricodar (VX-710) and timcodar (VX-853).Thioridazine inhibits gene expression control of the cell wall signaling pathway (CWI) in the human pathogenic fungus Paracoccidioides brasiliensis.Modulation of the norfloxacin resistance in Staphylococcus aureus by Cordia verbenaceae DC.Gallic acid-based indanone derivative interacts synergistically with tetracycline by inhibiting efflux pump in multidrug resistant E. coli.Homology modeling, molecular dynamics, and virtual screening of NorA efflux pump inhibitors of Staphylococcus aureus.Docking analysis insights quercetin can be a non-antibiotic adjuvant by inhibiting Mmr drug efflux pump in Mycobacterium sp. and its homologue EmrE in Escherichia coli.Phytochemical prospection and modulation of antibiotic activity in vitro by Lippia origanoides H.B.K. in methicillin resistant Staphylococcus aureus.New high-throughput screening assay to reveal similarities and differences in inhibitory sensitivities of multidrug ATP-binding cassette transporters.Novel non-neuroleptic phenothiazines inhibit Mycobacterium tuberculosis replication.Fluoxetine and thioridazine inhibit efflux and attenuate crystalline biofilm formation by Proteus mirabilis.
P2860
Q21133515-9C76397F-5864-447F-85D1-C361327ED303Q21133536-5D3161AF-542C-4CB2-B365-4C006E715786Q24609407-91512EC5-AC03-438A-B18B-6B46EE0685ECQ24650111-94C188FA-64C5-4FD5-95AD-DB1EB3BA7ECCQ27317346-727D2518-395F-411D-A112-2065ABD3E95BQ28477724-0F766C88-B94A-44ED-972D-FCECDD429368Q28483265-43925B67-15C8-4F15-B679-A0CCAA36B929Q28533525-3BE4475C-D758-46F4-8F78-7DCCA8DFA6AFQ33659230-ECFDBD70-5153-4C1C-A99C-9101A051D595Q33717526-9BE30F64-35C5-48D1-B87C-7A53646DB87EQ34301578-D81D37EA-1483-4B31-B61C-464B095552BAQ34510396-7DC86BC8-3DFD-46B8-9026-7652C073ACE6Q34647294-8C76C965-37E0-472A-BF99-F22852C94234Q35294152-8711CA81-5B6D-40AE-A679-E112DA8DAC2BQ35482558-AAC91129-C46C-47FE-BC2B-DE928620C3F7Q35635978-9719D97E-0C9F-48FA-8066-8DFD375136B8Q35743161-5F4C947E-7988-4126-9CB0-C68870C11BF5Q35962503-8D4A5F90-C2E1-4DCA-A7D4-EF0C1EAB9C14Q36150828-FB27F5E6-2B8B-438F-9969-860BE292603EQ36559376-831C4E87-F12A-4EE7-9B42-7F9C2197CAC6Q36673618-8A663890-E816-4B38-9102-72A8070C1A13Q36705837-C6A73E41-B3D0-4207-8F84-26C9574D82B7Q37947678-5A4B9C10-2589-4DBE-A24D-DA7D2FE7198DQ38168143-99373837-C093-4F27-AAE3-88ABBFB57309Q38599969-01A3E958-5F9F-485F-89C7-724551F54807Q38686020-FEFC68FD-DFB6-4C3B-A075-A5B72BB2422FQ38732092-57C2DE6F-F53C-4BEC-88AC-8669C6D42A22Q38955073-ADED94C3-EA69-4085-B0D2-DD5CF8B4EC96Q39312781-39509610-E9ED-4BED-9C9A-10385CE4B377Q40178903-5422BD92-127D-477B-8419-C7B8184A048CQ40289142-A45C6E7C-28CD-4D79-B460-38E9DB11E709Q40763094-B691C14C-51C2-4850-B711-A29C9307E967Q40824673-24415780-62FF-4E69-8F0A-880E5908836EQ40874282-0310C0A2-77A1-4435-81EC-75BA6705828EQ41367532-094265EB-7A04-4425-9830-2E3FA532B0D3Q41710215-8981B1A4-225D-4E7B-929E-E99A338E20B7Q41977158-796F5852-B992-461D-988C-AE744581BBB4Q42111717-7F9D462E-BA9E-4468-BD42-1AF9E7A03906Q42227061-D245D686-E75D-4B4D-9FB9-44F61E7C9AA3Q42263893-FF581142-CF08-413C-AE1F-40CB003B6DE9
P2860
Phenothiazines and thioxanthenes inhibit multidrug efflux pump activity in Staphylococcus aureus.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Phenothiazines and thioxanthen ...... vity in Staphylococcus aureus.
@en
Phenothiazines and thioxanthen ...... vity in Staphylococcus aureus.
@nl
type
label
Phenothiazines and thioxanthen ...... vity in Staphylococcus aureus.
@en
Phenothiazines and thioxanthen ...... vity in Staphylococcus aureus.
@nl
prefLabel
Phenothiazines and thioxanthen ...... vity in Staphylococcus aureus.
@en
Phenothiazines and thioxanthen ...... vity in Staphylococcus aureus.
@nl
P2093
P2860
P1476
Phenothiazines and thioxanthen ...... vity in Staphylococcus aureus.
@en
P2093
Glenn W Kaatz
Jette E Kristiansen
Susan M Seo
Varsha V Moudgal
P2860
P304
P356
10.1128/AAC.47.2.719-726.2003
P407
P577
2003-02-01T00:00:00Z